Cargando…
Natural product-derived icaritin exerts anti-glioblastoma effects by positively modulating estrogen receptor β
Glioblastoma is the most common malignancy of the central nervous system, and patients typically have a poor prognosis. Previous studies indicate a gender bias in the development of glioblastoma; women are at a lower risk compared with men, suggesting that estrogen may confer protective effects. Ica...
Autores principales: | Li, Xiaowen, Zhang, Weiwei, Liang, Lingli, Duan, Xiaoqun, Deng, Jianzhi, Zhou, Yuehan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086240/ https://www.ncbi.nlm.nih.gov/pubmed/32256768 http://dx.doi.org/10.3892/etm.2020.8571 |
Ejemplares similares
-
Toosendanin Exerts an Anti-Cancer Effect in Glioblastoma by Inducing Estrogen Receptor β- and p53-Mediated Apoptosis
por: Cao, Liang, et al.
Publicado: (2016) -
Icaritin, a novel FASN inhibitor, exerts anti-melanoma activities through IGF-1R/STAT3 signaling
por: Wu, Jinfeng, et al.
Publicado: (2016) -
Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy
por: Yang, Xiao-Jing, et al.
Publicado: (2019) -
A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods
por: Li, Haowen, et al.
Publicado: (2020) -
Icaritin alleviates docetaxel‐induced skin injury by suppressing reactive oxygen species via estrogen receptors
por: Zou, Jie, et al.
Publicado: (2021)